|Articles|November 10, 2015
Measuring Response to Treatment in Multiple Myeloma
Author(s)C. Ola Landgren
C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.
Advertisement
C. Ola Landgren, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses ways to measure response to treatment in multiple myeloma. Landgren addressed this topic in a talk last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals in New York City.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial
2
Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma
3
FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer
4
Effective Early Treatments Needed in Glioma, Real-World Data Finds
5
